{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:58:12Z","timestamp":1789495092283,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Proteins containing citrulline, a post-translational modification of arginine, are generated by peptidyl arginine deiminases (PAD). Citrullinated proteins have pro-inflammatory effects in both innate and adaptive immune responses. Here, we examine the therapeutic effects in collagen-induced arthritis of the second generation PAD inhibitor, BB-Cl-amidine. Treatment after disease onset resulted in the reversal of clinical and histological changes of arthritis, associated with a marked reduction in citrullinated proteins in lymph nodes. There was little overall change in antibodies to collagen or antibodies to citrullinated peptides, but a shift from pro-inflammatory Th1 and Th17-type responses to pro-resolution Th2-type responses was demonstrated by serum cytokines and antibody subtypes. In lymph node cells from the arthritic mice treated with BB-Cl-amidine, there was a decrease in total cell numbers but an increase in the proportion of Th2 cells. BB-Cl-amidine had a pro-apoptotic effect on all Th subsets <jats:italic>in vitro<\/jats:italic> with Th17 cells appearing to be the most sensitive. We suggest that these immunoregulatory effects of PAD inhibition in CIA are complex, but primarily mediated by transcriptional regulation. We suggest that targeting PADs is a promising strategy for the treatment of chronic inflammatory disease.<\/jats:p>","DOI":"10.1038\/srep26430","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T06:30:42Z","timestamp":1464071442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses"],"prefix":"10.1038","volume":"6","author":[{"given":"Joanna","family":"Kawalkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Quirke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataraman","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas B.","family":"La Thangue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Venables","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"BFsrep26430_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","volume":"233","author":"N Wegner","year":"2010","unstructured":"Wegner, N. et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34\u201354 (2010).","journal-title":"Immunol. Rev."},{"key":"BFsrep26430_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrrheum.2015.7","volume":"11","author":"K Yamamoto","year":"2015","unstructured":"Yamamoto, K., Okada, Y., Suzuki, A. & Kochi, Y. Genetics of rheumatoid arthritis in Asia-present and future. Nat. Rev. Rheumatol. 11, 375\u2013379 (2015).","journal-title":"Nat. Rev. Rheumatol"},{"key":"BFsrep26430_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2004.08.020","volume":"118","author":"GL Cuthbert","year":"2004","unstructured":"Cuthbert, G. L. et al. Histone deimination antagonizes arginine methylation. Cell 118, 545\u201353 (2004).","journal-title":"Cell"},{"key":"BFsrep26430_CR4","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.23618","volume":"58","author":"A Kinloch","year":"2008","unstructured":"Kinloch, A. et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 58, 2287\u201395 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFsrep26430_CR5","doi-asserted-by":"publisher","first-page":"13331","DOI":"10.1073\/pnas.1203280109","volume":"109","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor target gene activation. Proc. Natl. Acad. Sci. USA 109, 13331\u20136 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep26430_CR6","first-page":"207","volume":"98","author":"RO Williams","year":"2004","unstructured":"Williams, R. O. Collagen-induced arthritis as a model for rheumatoid arthritis. Methods Mol. Med. 98, 207\u201316 (2004).","journal-title":"Methods Mol. Med."},{"key":"BFsrep26430_CR7","doi-asserted-by":"crossref","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice. Ann. Rheum. Dis. (2014). doi: 10.1136\/annrheumdis-2014-205365.","DOI":"10.1136\/annrheumdis-2014-205365"},{"key":"BFsrep26430_CR8","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.4049\/jimmunol.1001620","volume":"186","author":"VC Willis","year":"2011","unstructured":"Willis, V. C. et al. N-\u03b1-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J. Immunol. 186, 4396\u2013404 (2011).","journal-title":"J. Immunol."},{"key":"BFsrep26430_CR9","doi-asserted-by":"crossref","unstructured":"Quirke, A.-M. et al. Bronchiectasis: A model for chronic bacterial infection inducing autoimmunity in rheumatoid arthritis. Arthritis Rheumatol. (Hoboken, N. J.) (2015). doi: 10.1002\/art.39226.","DOI":"10.1002\/art.39226"},{"key":"BFsrep26430_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/art.25059","volume":"62","author":"AL Feitsma","year":"2010","unstructured":"Feitsma, A. L. et al. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. Arthritis Rheum. 62, 117\u2013125 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFsrep26430_CR11","doi-asserted-by":"publisher","first-page":"G929","DOI":"10.1152\/ajpgi.00435.2010","volume":"300","author":"AA Chumanevich","year":"2011","unstructured":"Chumanevich, A. A. et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G929\u201338 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFsrep26430_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1161\/CIRCRESAHA.114.303312","volume":"114","author":"JS Knight","year":"2014","unstructured":"Knight, J. S. et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ. Res. 114, 947\u201356 (2014).","journal-title":"Circ. Res."},{"key":"BFsrep26430_CR13","unstructured":"Willis, V. C. The role of citrullination in the development of mouse and human inflammatory arthritis, PhD Thesis, University Colorado (2012) http:\/\/hdl.handle.net\/10968\/233."},{"key":"BFsrep26430_CR14","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/art.38393","volume":"66","author":"MA Shelef","year":"2014","unstructured":"Shelef, M. A. et al. Peptidylarginine deiminase 4 contributes to tumor necrosis factor \u03b1-induced inflammatory arthritis. Arthritis Rheumatol. (Hoboken, N. J.) 66, 1482\u201391 (2014).","journal-title":"Arthritis Rheumatol. (Hoboken, N. J.)"},{"key":"BFsrep26430_CR15","doi-asserted-by":"publisher","first-page":"13041","DOI":"10.1038\/srep13041","volume":"5","author":"Y Seri","year":"2015","unstructured":"Seri, Y. et al. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci. Rep. 5, 13041 (2015).","journal-title":"Sci. Rep"},{"key":"BFsrep26430_CR16","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/ar3829","volume":"14","author":"AS Rohrbach","year":"2012","unstructured":"Rohrbach, A. S., Hemmers, S., Arandjelovic, S., Corr, M. & Mowen, K. A. PAD4 is not essential for disease in the K\/BxN murine autoantibody-mediated model of arthritis. Arthritis Res. Ther. 14, R104 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFsrep26430_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nchembio.1735","volume":"11","author":"HD Lewis","year":"2015","unstructured":"Lewis, H. D. et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat. Chem. Biol. 11, 189\u201391 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"BFsrep26430_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/38444","volume":"389","author":"K Luger","year":"1997","unstructured":"Luger, K., M\u00e4der, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251\u201360 (1997).","journal-title":"Nature"},{"key":"BFsrep26430_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-015-0520-x","volume":"17","author":"EB Lugli","year":"2015","unstructured":"Lugli, E. B. et al. Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis. Arthritis Res. Ther. 17, 9 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFsrep26430_CR20","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/art.11229","volume":"48","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar, E. R. et al. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 48, 2489\u2013500 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFsrep26430_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrrheum.2009.179","volume":"5","author":"WB van den Berg","year":"2009","unstructured":"van den Berg, W. B. & Miossec, P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 549\u201353 (2009).","journal-title":"Nat. Rev. Rheumatol"},{"key":"BFsrep26430_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang, X. O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28, 29\u201339 (2008).","journal-title":"Immunity"},{"key":"BFsrep26430_CR23","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.4049\/jimmunol.0802246","volume":"182","author":"S Shahrara","year":"2009","unstructured":"Shahrara, S., Pickens, S. R., Dorfleutner, A. & Pope, R. M. IL-17 induces monocyte migration in rheumatoid arthritis. J. Immunol. 182, 3884\u201391 (2009).","journal-title":"J. Immunol."},{"key":"BFsrep26430_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","volume":"115","author":"M Pelletier","year":"2010","unstructured":"Pelletier, M. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335\u201343 (2010).","journal-title":"Blood"},{"key":"BFsrep26430_CR25","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic, D. V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160, 3513\u201321 (1998).","journal-title":"J. Immunol."},{"key":"BFsrep26430_CR26","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1084\/jem.20072707","volume":"205","author":"CA Notley","year":"2008","unstructured":"Notley, C. A. et al. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J. Exp. Med. 205, 2491\u20137 (2008).","journal-title":"J. Exp. Med."},{"key":"BFsrep26430_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/art.20885","volume":"52","author":"MI Koenders","year":"2005","unstructured":"Koenders, M. I. et al. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum. 52, 975\u201383 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFsrep26430_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrrheum.2009.80","volume":"5","author":"F Annunziato","year":"2009","unstructured":"Annunziato, F., Cosmi, L., Liotta, F., Maggi, E. & Romagnani, S. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat. Rev. Rheumatol. 5, 325\u201331 (2009).","journal-title":"Nat. Rev. Rheumatol"},{"key":"BFsrep26430_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/ard.2003.012211","volume":"63","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar, E. R. et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 63, 373\u201381 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"BFsrep26430_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1189\/jlb.3A0314-142RR","volume":"97","author":"B Jang","year":"2015","unstructured":"Jang, B. et al. Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings. J. Leukoc. Biol. 97, 351\u201362 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"BFsrep26430_CR31","doi-asserted-by":"publisher","first-page":"205156","DOI":"10.1155\/2015\/205156","volume":"2015","author":"J Bystrom","year":"2015","unstructured":"Bystrom, J. et al. Harnessing the Therapeutic Potential of Th17 Cells. Mediators Inflamm. 2015, 205156 (2015).","journal-title":"Mediators Inflamm."},{"key":"BFsrep26430_CR32","doi-asserted-by":"crossref","unstructured":"Kawalkowska, J. Z. et al. Targeted IL-4 therapy synergizes with dexamethasone to induce a state of tolerance by promoting Treg cells and macrophages in mice with arthritis. Eur. J. Immunol. (2016). doi: 10.1002\/eji.201546221.","DOI":"10.1002\/eji.201546221"},{"key":"BFsrep26430_CR33","doi-asserted-by":"publisher","first-page":"e48635","DOI":"10.1371\/journal.pone.0048635","volume":"7","author":"SM Farooq","year":"2012","unstructured":"Farooq, S. M. & Ashour, H. M. Type II collagen induces peripheral tolerance in BALB\/c mice via the generation of CD8+ T regulatory cells. Plos One 7, e48635 (2012).","journal-title":"Plos One"},{"key":"BFsrep26430_CR34","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/jmf.2013.2911","volume":"16","author":"O Yoshinari","year":"2013","unstructured":"Yoshinari, O. et al. Water-soluble undenatured type II collagen ameliorates collagen-induced arthritis in mice. J. Med. Food 16, 1039\u201345 (2013).","journal-title":"J. Med. Food"},{"key":"BFsrep26430_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/mus.23488","volume":"46","author":"J Rowin","year":"2012","unstructured":"Rowin, J. et al. Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: effects on regulatory T cells. Muscle Nerve 46, 449\u201353 (2012).","journal-title":"Muscle Nerve"},{"key":"BFsrep26430_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cyto.2015.05.030","volume":"75","author":"P Bhattacharya","year":"2015","unstructured":"Bhattacharya, P. et al. GM-CSF: An immune modulatory cytokine that can suppress autoimmunity. Cytokine 75, 261\u201371 (2015).","journal-title":"Cytokine"},{"key":"BFsrep26430_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/sj.gt.3300436","volume":"4","author":"Y Chernajovsky","year":"1997","unstructured":"Chernajovsky, Y., Adams, G., Triantaphyllopoulos, K., Ledda, M. F. & Podhajcer, O. L. Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model. Gene Ther. 4, 553\u20139 (1997).","journal-title":"Gene Ther"},{"key":"BFsrep26430_CR38","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.4049\/jimmunol.159.11.5687","volume":"159","author":"AC Horsfall","year":"1997","unstructured":"Horsfall, A. C. et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J. Immunol. 159, 5687\u201396 (1997).","journal-title":"J. Immunol."},{"key":"BFsrep26430_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel, D. & Fl\u00fcgge, U. I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141\u20133 (1984).","journal-title":"Anal. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep26430","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:36:43Z","timestamp":1672843003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep26430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,19]]}},"alternative-id":["BFsrep26430"],"URL":"https:\/\/doi.org\/10.1038\/srep26430","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]},"assertion":[{"value":"1 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.R.T. has received compensation as the founder and consultant to \u201cPADlock Therapeutics\u201d. All other authors declare no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26430"}}